Search research articles
Contact Us
Filters
Showing results (61-70 of 192) with videos related to
Page
of 20
Sort By:
Journal of Biopharmaceutical Statistics
|
April 29, 2025
Application of complete N-of-1 trial design in bioequivalence-biosimilar drug development
Yuqing Liu, Wendy Lou, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
July 31, 2002
Probability lower bounds for USP/NF tests
Shein-Chung Chow, Jun Shao, Hansheng Wang
Journal of Biopharmaceutical Statistics
|
December 10, 2016
Sample size requirement in analytical studies for similarity assessment
Shein-Chung Chow, Fuyu Song, He Bai
Journal of Biopharmaceutical Statistics
|
December 3, 2016
On safety margin for drug interchangeability
Jiayin Zheng, Shein-Chung Chow, Fuyu Song
Journal of Biopharmaceutical Statistics
|
May 13, 2008
On power and sample size calculation for QT studies with recording replicates at given time point
Shein-Chung Chow, Bin Cheng, Dennis Cosmatos
Statistics in Medicine
|
May 13, 2017
On assessing bioequivalence and interchangeability between generics based on indirect comparisons
Jiayin Zheng, Shein-Chung Chow, Mengdie Yuan
Journal of Biopharmaceutical Statistics
|
December 13, 2002
A note on sample size calculation for mean comparisons based on noncentral t-statistics
Shein-Chung Chow, Jun Shao, Hansheng Wang
Journal of Biopharmaceutical Statistics
|
June 2, 2012
On the independence of data monitoring committee in adaptive design clinical trials
Shein-Chung Chow, Ralph Corey, Min Lin
Statistics in Medicine
|
May 19, 2005
Statistical inference for cancer trials with treatment switching
Jun Shao, Mark Chang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
April 12, 2025
The role of regulatory flexibility in the review and approval process of rare disease drug development
Shein-Chung Chow, Anne Pariser, Steven Galson
Page
of 20
Search research articles
Search
Showing results (61-70 of 192) with videos related to
Sort By:
Page
of 20
Journal of Biopharmaceutical Statistics
|
April 29, 2025
Application of complete N-of-1 trial design in bioequivalence-biosimilar drug development
Yuqing Liu, Wendy Lou, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
July 31, 2002
Probability lower bounds for USP/NF tests
Shein-Chung Chow, Jun Shao, Hansheng Wang
Journal of Biopharmaceutical Statistics
|
December 10, 2016
Sample size requirement in analytical studies for similarity assessment
Shein-Chung Chow, Fuyu Song, He Bai
Journal of Biopharmaceutical Statistics
|
December 3, 2016
On safety margin for drug interchangeability
Jiayin Zheng, Shein-Chung Chow, Fuyu Song
Journal of Biopharmaceutical Statistics
|
May 13, 2008
On power and sample size calculation for QT studies with recording replicates at given time point
Shein-Chung Chow, Bin Cheng, Dennis Cosmatos
Statistics in Medicine
|
May 13, 2017
On assessing bioequivalence and interchangeability between generics based on indirect comparisons
Jiayin Zheng, Shein-Chung Chow, Mengdie Yuan
Journal of Biopharmaceutical Statistics
|
December 13, 2002
A note on sample size calculation for mean comparisons based on noncentral t-statistics
Shein-Chung Chow, Jun Shao, Hansheng Wang
Journal of Biopharmaceutical Statistics
|
June 2, 2012
On the independence of data monitoring committee in adaptive design clinical trials
Shein-Chung Chow, Ralph Corey, Min Lin
Statistics in Medicine
|
May 19, 2005
Statistical inference for cancer trials with treatment switching
Jun Shao, Mark Chang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
April 12, 2025
The role of regulatory flexibility in the review and approval process of rare disease drug development
Shein-Chung Chow, Anne Pariser, Steven Galson
Page
of 20